KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Short-term Investments: 2010-2024

Historic Short-term Investments for Dynavax Technologies (DVAX) over the last 15 years, with Dec 2024 value amounting to $618.0 million.

  • Dynavax Technologies' Short-term Investments fell 24.37% to $487.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $487.6 million, marking a year-over-year decrease of 24.37%. This contributed to the annual value of $618.0 million for FY2024, which is 4.38% up from last year.
  • Latest data reveals that Dynavax Technologies reported Short-term Investments of $618.0 million as of FY2024, which was up 4.38% from $592.0 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Short-term Investments registered a high of $618.0 million during FY2024, and its lowest value of $109.8 million during FY2021.
  • Over the past 3 years, Dynavax Technologies' median Short-term Investments value was $592.0 million (recorded in 2023), while the average stood at $544.1 million.
  • Per our database at Business Quant, Dynavax Technologies' Short-term Investments decreased by 17.45% in 2021 and then surged by 284.83% in 2022.
  • Over the past 5 years, Dynavax Technologies' Short-term Investments (Yearly) stood at $133.0 million in 2020, then fell by 17.45% to $109.8 million in 2021, then surged by 284.83% to $422.4 million in 2022, then surged by 40.16% to $592.0 million in 2023, then grew by 4.38% to $618.0 million in 2024.